Oligodendroglioma Treatment Market Report

China Oligodendroglioma Treatment Industry Market Research Report 2023-2029

  • POSTDATE：Sep 08, 2023
  • PAGES：204
  • REPORT CODE：GMM1782859
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Oligodendroglioma Treatment industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Novartis AG

    • Pfizer Inc

    • Immatics Biotechnologies GmbH

    • Millennium Pharmaceuticals Inc

    • Cavion LLC

    • Bristol-Myers Squibb Co

    • Boehringer Ingelheim GmbH

    • F Hoffmann-La Roche Ltd

    • Ipsen SA

    • Leadiant Biosciences Inc

    • AngioChem Inc

    • Celldex Therapeutics Inc

    • Tocagen Inc

    By Type:

    • Others

    • Alisertib

    • Bevacizumab

    • IMA-950

    • Dasatinib

    • DCVax-L

    • CDX-1401

    By Application:

    • Clinic

    • ASCs

    • Hospital

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Oligodendroglioma Treatment Market Overview 2018-2029

    • 1.1 China Oligodendroglioma Treatment Industry Development Overview

    • 1.2 China Oligodendroglioma Treatment Industry Development History

    • 1.3 China Oligodendroglioma Treatment Industry Market Size (2018-2029)

    • 1.4 China Oligodendroglioma Treatment Market Analysis by Type from Production Side

      • 1.4.1 China Oligodendroglioma Treatment Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.2 China Oligodendroglioma Treatment Production Volume, Production Value and Growth Rate of Alisertib (2018-2029)

      • 1.4.3 China Oligodendroglioma Treatment Production Volume, Production Value and Growth Rate of Bevacizumab (2018-2029)

      • 1.4.4 China Oligodendroglioma Treatment Production Volume, Production Value and Growth Rate of IMA-950 (2018-2029)

      • 1.4.5 China Oligodendroglioma Treatment Production Volume, Production Value and Growth Rate of Dasatinib (2018-2029)

      • 1.4.6 China Oligodendroglioma Treatment Production Volume, Production Value and Growth Rate of DCVax-L (2018-2029)

      • 1.4.7 China Oligodendroglioma Treatment Production Volume, Production Value and Growth Rate of CDX-1401 (2018-2029)

    • 1.5 China Oligodendroglioma Treatment Market Analysis by Application from Consumption End

      • 1.5.1 China Oligodendroglioma Treatment Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

      • 1.5.2 China Oligodendroglioma Treatment Sales Volume, Sales Value and Growth Rate of ASCs (2018-2029)

      • 1.5.3 China Oligodendroglioma Treatment Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • 1.6 China Oligodendroglioma Treatment Market Analysis by Region

      • 1.6.1 North China Oligodendroglioma Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Oligodendroglioma Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Oligodendroglioma Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Oligodendroglioma Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Oligodendroglioma Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Oligodendroglioma Treatment Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Oligodendroglioma Treatment Market Size and Growth Rate from 2018-2029

    Chapter 2 China Oligodendroglioma Treatment Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Oligodendroglioma Treatment Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Oligodendroglioma Treatment Market Status and Competition Analysis in 2023

      • 2.2.3 China Oligodendroglioma Treatment Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Oligodendroglioma Treatment Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Oligodendroglioma Treatment Industry Development

    Chapter 3 Oligodendroglioma TreatmentIndustry Chain Analysis

    • 3.1 Oligodendroglioma Treatment Industry Chain

    • 3.2 Oligodendroglioma Treatment Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Oligodendroglioma Treatment Market

    • 3.3 Oligodendroglioma Treatment Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Oligodendroglioma Treatment Market

    Chapter 4 China Oligodendroglioma Treatment Market, by Type

    • 4.1 China Oligodendroglioma Treatment Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Oligodendroglioma Treatment Total Production Volume and Growth Rate from Production Side

    • 4.5 China Oligodendroglioma Treatment Production Volume and Growth Rate, by Type

      • 4.5.1 China Oligodendroglioma Treatment Production Volume and Growth Rate of Others

      • 4.5.2 China Oligodendroglioma Treatment Production Volume and Growth Rate of Alisertib

      • 4.5.3 China Oligodendroglioma Treatment Production Volume and Growth Rate of Bevacizumab

      • 4.5.4 China Oligodendroglioma Treatment Production Volume and Growth Rate of IMA-950

      • 4.5.5 China Oligodendroglioma Treatment Production Volume and Growth Rate of Dasatinib

      • 4.5.6 China Oligodendroglioma Treatment Production Volume and Growth Rate of DCVax-L

      • 4.5.7 China Oligodendroglioma Treatment Production Volume and Growth Rate of CDX-1401

    Chapter 5 China Oligodendroglioma Treatment Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Oligodendroglioma Treatment Total Market Size and Growth Rate from Consumption End

    • 5.5 China Oligodendroglioma Treatment Market Size and Growth Rate, by Application

      • 5.5.1 China Oligodendroglioma Treatment Market Size and Growth Rate of Clinic

      • 5.5.2 China Oligodendroglioma Treatment Market Size and Growth Rate of ASCs

      • 5.5.3 China Oligodendroglioma Treatment Market Size and Growth Rate of Hospital

    Chapter 6 China Oligodendroglioma Treatment Market, by Region

    • 6.1 China Oligodendroglioma Treatment Production Volume and Production Value, by Region

    • 6.2 China Oligodendroglioma Treatment Sales Volume and Sales Value, by Region

    Chapter 7 North China Oligodendroglioma Treatment Market Analysis

    • 7.1 North China Oligodendroglioma Treatment Market, by Type

    • 7.2 North China Oligodendroglioma Treatment Market, by Application

    Chapter 8 Central China Oligodendroglioma Treatment Market Analysis

    • 8.1 Central China Oligodendroglioma Treatment Market, by Type

    • 8.2 Central China Oligodendroglioma Treatment Market, by Application

    Chapter 9 South China Oligodendroglioma Treatment Market Analysis

    • 9.1 South China Oligodendroglioma Treatment Market, by Type

    • 9.2 South China Oligodendroglioma Treatment Market, by Application

    Chapter 10 East China Oligodendroglioma Treatment Market Analysis

    • 10.1 East China Oligodendroglioma Treatment Market, by Type

    • 10.2 East China Oligodendroglioma Treatment Market, by Application

    Chapter 11 Northeast China Oligodendroglioma Treatment Market Analysis

    • 11.1 Northeast China Oligodendroglioma Treatment Market, by Type

    • 11.2 Northeast China Oligodendroglioma Treatment Market, by Application

    Chapter 12 Southwest China Oligodendroglioma Treatment Market Analysis

    • 12.1 Southwest China Oligodendroglioma Treatment Market, by Type

    • 12.2 Southwest China Oligodendroglioma Treatment Market, by Application

    Chapter 13 Northwest China Oligodendroglioma Treatment Market Analysis

    • 13.1 Northwest China Oligodendroglioma Treatment Market, by Type

    • 13.2 Northwest China Oligodendroglioma Treatment Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Novartis AG

        • 14.1.1 Novartis AG Company Profile

        • 14.1.2 Novartis AG Oligodendroglioma Treatment Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Pfizer Inc

        • 14.2.1 Pfizer Inc Company Profile

        • 14.2.2 Pfizer Inc Oligodendroglioma Treatment Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Immatics Biotechnologies GmbH

        • 14.3.1 Immatics Biotechnologies GmbH Company Profile

        • 14.3.2 Immatics Biotechnologies GmbH Oligodendroglioma Treatment Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Millennium Pharmaceuticals Inc

        • 14.4.1 Millennium Pharmaceuticals Inc Company Profile

        • 14.4.2 Millennium Pharmaceuticals Inc Oligodendroglioma Treatment Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Cavion LLC

        • 14.5.1 Cavion LLC Company Profile

        • 14.5.2 Cavion LLC Oligodendroglioma Treatment Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Bristol-Myers Squibb Co

        • 14.6.1 Bristol-Myers Squibb Co Company Profile

        • 14.6.2 Bristol-Myers Squibb Co Oligodendroglioma Treatment Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Boehringer Ingelheim GmbH

        • 14.7.1 Boehringer Ingelheim GmbH Company Profile

        • 14.7.2 Boehringer Ingelheim GmbH Oligodendroglioma Treatment Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 F Hoffmann-La Roche Ltd

        • 14.8.1 F Hoffmann-La Roche Ltd Company Profile

        • 14.8.2 F Hoffmann-La Roche Ltd Oligodendroglioma Treatment Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Ipsen SA

        • 14.9.1 Ipsen SA Company Profile

        • 14.9.2 Ipsen SA Oligodendroglioma Treatment Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Leadiant Biosciences Inc

        • 14.10.1 Leadiant Biosciences Inc Company Profile

        • 14.10.2 Leadiant Biosciences Inc Oligodendroglioma Treatment Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 AngioChem Inc

        • 14.11.1 AngioChem Inc Company Profile

        • 14.11.2 AngioChem Inc Oligodendroglioma Treatment Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Celldex Therapeutics Inc

        • 14.12.1 Celldex Therapeutics Inc Company Profile

        • 14.12.2 Celldex Therapeutics Inc Oligodendroglioma Treatment Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Tocagen Inc

        • 14.13.1 Tocagen Inc Company Profile

        • 14.13.2 Tocagen Inc Oligodendroglioma Treatment Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Oligodendroglioma Treatment Industry Research Conclusions

    • 15.2 Oligodendroglioma Treatment Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Oligodendroglioma Treatment Industry Market Size (2018-2029)

    • Figure China Oligodendroglioma Treatment Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Oligodendroglioma Treatment Production Volume, Production Value and Growth Rate of Alisertib (2018-2029)

    • Figure China Oligodendroglioma Treatment Production Volume, Production Value and Growth Rate of Bevacizumab (2018-2029)

    • Figure China Oligodendroglioma Treatment Production Volume, Production Value and Growth Rate of IMA-950 (2018-2029)

    • Figure China Oligodendroglioma Treatment Production Volume, Production Value and Growth Rate of Dasatinib (2018-2029)

    • Figure China Oligodendroglioma Treatment Production Volume, Production Value and Growth Rate of DCVax-L (2018-2029)

    • Figure China Oligodendroglioma Treatment Production Volume, Production Value and Growth Rate of CDX-1401 (2018-2029)

    • Figure China Oligodendroglioma Treatment Sales Volume, Sales Value and Growth Rate of Clinic (2018-2029)

    • Figure China Oligodendroglioma Treatment Sales Volume, Sales Value and Growth Rate of ASCs (2018-2029)

    • Figure China Oligodendroglioma Treatment Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)

    • Figure North China Oligodendroglioma Treatment Market Size and Growth Rate from 2018-2029

    • Figure Central China Oligodendroglioma Treatment Market Size and Growth Rate from 2018-2029

    • Figure South China Oligodendroglioma Treatment Market Size and Growth Rate from 2018-2029

    • Figure East China Oligodendroglioma Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Oligodendroglioma Treatment Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Oligodendroglioma Treatment Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Oligodendroglioma Treatment Market Size and Growth Rate from 2018-2029

    • Figure Oligodendroglioma Treatment Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Oligodendroglioma Treatment Market Share by Type in 2018

    • Figure China Oligodendroglioma Treatment Market Share by Type in 2023

    • Figure China Oligodendroglioma Treatment Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Oligodendroglioma Treatment Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Oligodendroglioma Treatment Production Volume and Growth Rate of Alisertib (2018-2023)

    • Figure China Oligodendroglioma Treatment Production Volume and Growth Rate of Bevacizumab (2018-2023)

    • Figure China Oligodendroglioma Treatment Production Volume and Growth Rate of IMA-950 (2018-2023)

    • Figure China Oligodendroglioma Treatment Production Volume and Growth Rate of Dasatinib (2018-2023)

    • Figure China Oligodendroglioma Treatment Production Volume and Growth Rate of DCVax-L (2018-2023)

    • Figure China Oligodendroglioma Treatment Production Volume and Growth Rate of CDX-1401 (2018-2023)

    • Figure China Oligodendroglioma Treatment Market Share by Application in 2018

    • Figure China Oligodendroglioma Treatment Market Share by Application in 2023

    • Figure China Oligodendroglioma Treatment Total Market Size and Growth Rate from Consumption End

    • Figure China Oligodendroglioma Treatment Market Size and Growth Rate of Clinic (2018-2023)

    • Figure China Oligodendroglioma Treatment Market Size and Growth Rate of ASCs (2018-2023)

    • Figure China Oligodendroglioma Treatment Market Size and Growth Rate of Hospital (2018-2023)

    • Table China Oligodendroglioma Treatment Production Volume by Region (2018-2023)

    • Table China Oligodendroglioma Treatment Production Volume Share by Region (2018-2023)

    • Figure China Oligodendroglioma Treatment Production Volume Share by Region (2018-2023)

    • Table China Oligodendroglioma Treatment Production Value by Region (2018-2023)

    • Table China Oligodendroglioma Treatment Production Value Share by Region (2018-2023)

    • Figure China Oligodendroglioma Treatment Production Value Share by Region (2018-2023)

    • Table China Oligodendroglioma Treatment Sales Volume by Region (2018-2023)

    • Table China Oligodendroglioma Treatment Sales Volume Share by Region (2018-2023)

    • Figure China Oligodendroglioma Treatment Sales Volume Share by Region (2018-2023)

    • Table China Oligodendroglioma Treatment Sales Value by Region (2018-2023)

    • Table China Oligodendroglioma Treatment Sales Value Share by Region (2018-2023)

    • Figure China Oligodendroglioma Treatment Sales Value Share by Region (2018-2023)

    • Table North China Oligodendroglioma Treatment Production Volume by Type (2018-2023)

    • Table North China Oligodendroglioma Treatment Production Volume Share by Type (2018-2023)

    • Figure North China Oligodendroglioma Treatment Production Volume Share by Type (2018-2023)

    • Table North China Oligodendroglioma Treatment Sales Volume by Application (2018-2023)

    • Table North China Oligodendroglioma Treatment Sales Volume Share by Application (2018-2023)

    • Figure North China Oligodendroglioma Treatment Sales Volume Share by Application (2018-2023)

    • Table Central China Oligodendroglioma Treatment Production Volume by Type (2018-2023)

    • Table Central China Oligodendroglioma Treatment Production Volume Share by Type (2018-2023)

    • Figure Central China Oligodendroglioma Treatment Production Volume Share by Type (2018-2023)

    • Table Central China Oligodendroglioma Treatment Sales Volume by Application (2018-2023)

    • Table Central China Oligodendroglioma Treatment Sales Volume Share by Application (2018-2023)

    • Figure Central China Oligodendroglioma Treatment Sales Volume Share by Application (2018-2023)

    • Table South China Oligodendroglioma Treatment Production Volume by Type (2018-2023)

    • Table South China Oligodendroglioma Treatment Production Volume Share by Type (2018-2023)

    • Figure South China Oligodendroglioma Treatment Production Volume Share by Type (2018-2023)

    • Table South China Oligodendroglioma Treatment Sales Volume by Application (2018-2023)

    • Table South China Oligodendroglioma Treatment Sales Volume Share by Application (2018-2023)

    • Figure South China Oligodendroglioma Treatment Sales Volume Share by Application (2018-2023)

    • Table East China Oligodendroglioma Treatment Production Volume by Type (2018-2023)

    • Table East China Oligodendroglioma Treatment Production Volume Share by Type (2018-2023)

    • Figure East China Oligodendroglioma Treatment Production Volume Share by Type (2018-2023)

    • Table East China Oligodendroglioma Treatment Sales Volume by Application (2018-2023)

    • Table East China Oligodendroglioma Treatment Sales Volume Share by Application (2018-2023)

    • Figure East China Oligodendroglioma Treatment Sales Volume Share by Application (2018-2023)

    • Table Northeast China Oligodendroglioma Treatment Production Volume by Type (2018-2023)

    • Table Northeast China Oligodendroglioma Treatment Production Volume Share by Type (2018-2023)

    • Figure Northeast China Oligodendroglioma Treatment Production Volume Share by Type (2018-2023)

    • Table Northeast China Oligodendroglioma Treatment Sales Volume by Application (2018-2023)

    • Table Northeast China Oligodendroglioma Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Oligodendroglioma Treatment Sales Volume Share by Application (2018-2023)

    • Table Southwest China Oligodendroglioma Treatment Production Volume by Type (2018-2023)

    • Table Southwest China Oligodendroglioma Treatment Production Volume Share by Type (2018-2023)

    • Figure Southwest China Oligodendroglioma Treatment Production Volume Share by Type (2018-2023)

    • Table Southwest China Oligodendroglioma Treatment Sales Volume by Application (2018-2023)

    • Table Southwest China Oligodendroglioma Treatment Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Oligodendroglioma Treatment Sales Volume Share by Application (2018-2023)

    • Table Northwest China Oligodendroglioma Treatment Production Volume by Type (2018-2023)

    • Table Northwest China Oligodendroglioma Treatment Production Volume Share by Type (2018-2023)

    • Figure Northwest China Oligodendroglioma Treatment Production Volume Share by Type (2018-2023)

    • Table Northwest China Oligodendroglioma Treatment Sales Volume by Application (2018-2023)

    • Table Northwest China Oligodendroglioma Treatment Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Oligodendroglioma Treatment Sales Volume Share by Application (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Oligodendroglioma Treatment Revenue, Price and Gross (2018-2023)

    • Table Pfizer Inc Company Profile

    • Table Pfizer Inc Oligodendroglioma Treatment Revenue, Price and Gross (2018-2023)

    • Table Immatics Biotechnologies GmbH Company Profile

    • Table Immatics Biotechnologies GmbH Oligodendroglioma Treatment Revenue, Price and Gross (2018-2023)

    • Table Millennium Pharmaceuticals Inc Company Profile

    • Table Millennium Pharmaceuticals Inc Oligodendroglioma Treatment Revenue, Price and Gross (2018-2023)

    • Table Cavion LLC Company Profile

    • Table Cavion LLC Oligodendroglioma Treatment Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Co Company Profile

    • Table Bristol-Myers Squibb Co Oligodendroglioma Treatment Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim GmbH Company Profile

    • Table Boehringer Ingelheim GmbH Oligodendroglioma Treatment Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche Ltd Company Profile

    • Table F Hoffmann-La Roche Ltd Oligodendroglioma Treatment Revenue, Price and Gross (2018-2023)

    • Table Ipsen SA Company Profile

    • Table Ipsen SA Oligodendroglioma Treatment Revenue, Price and Gross (2018-2023)

    • Table Leadiant Biosciences Inc Company Profile

    • Table Leadiant Biosciences Inc Oligodendroglioma Treatment Revenue, Price and Gross (2018-2023)

    • Table AngioChem Inc Company Profile

    • Table AngioChem Inc Oligodendroglioma Treatment Revenue, Price and Gross (2018-2023)

    • Table Celldex Therapeutics Inc Company Profile

    • Table Celldex Therapeutics Inc Oligodendroglioma Treatment Revenue, Price and Gross (2018-2023)

    • Table Tocagen Inc Company Profile

    • Table Tocagen Inc Oligodendroglioma Treatment Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US